Skip to main content
. 2021 Feb 22;53(2):2761. doi: 10.2340/16501977-2801

Table I.

Baseline demographics and severity of presentation

Parameter Effectiveness Set (n = 953)*
Age, years, mean (SD) 54.0 (15.3)
Sex, n (%) Male 537 (56)
Time since onset of the event leading to upper limb spasticity, years
 Mean (SD) 7.6 (9.4)
 Median (IQR) 4.2 (6.5)
Diagnosis of condition leading to upper limb spasticity, n (%)
 Acquired brain injury (stroke/trauma/other) 870 (91.3)
 Spinal cord injury 15 (1.6)
 Progressive neurological condition 20 (2.1)
 Congenital 44 (4.6)
 Other 4 (0.4)
Aetiology, n (%)
 Trauma 71 (7.5)
 Vascular (infarct or haemorrhage) 786 (82.5)
 Hypoxic 25 (2.6)
 Inflammatory/infective 15 (1.6)
 Tumour 19 (2.0)
 Degenerative 12 (1.3)
 Cerebral palsy 10 (1.0)
 Other 15 (1.6)
Spasticity distribution, n (%)
 Focal (part of the limb) 190 (19.9)
 Regional 763 (80.1)
Affected limb, n (%)
 Right arm 409 (42.9)
 Left arm 488 (51.2)
 Both arms 56 (5.9)
From the Neurological Impairment Scale
Motor impairment, n (%)** n = 908*
 Impaired muscle power 783 (86.2)
 Impaired control of voluntary movement 540 (59.5)
 Proximal motor impairment 828 (91.2)
 Distal motor impairment 859 (94.6)
Confounding factors, n (%)** n = 914*
 Severe weakness 416 (45.5)
 Impaired mobility of joints 631 (69.0)
 Communication impairment 397 (43.4)
 Emotional/behaviour impairment 309 (33.8)
 Impaired cognitive function 289 (31.6)
 Sensation impairment (n = 913) 484 (53.0)
*

Not all patients had assessments of impairments; data are presented for patients with available data.

**

Defined as at least mild severity on the Upper Limb Spasticity adapted Neurological Impairment Scale (ULS-NIS), except for the presence of severe weakness, which was assessed as yes/no.

IQR: interquartile range; SD: standard deviation.